Core Viewpoint - Herbal Dispatch Inc. has amended the terms of its unsecured convertible debentures, extending the maturity date from January 31, 2026, to January 31, 2028, while maintaining other terms such as a 14% annual interest rate and a conversion price of CAD$0.06 [1][2]. Group 1: Amendment Details - The final amendment to the Convertible Debentures extends the maturity date to January 31, 2028, with the interest rate remaining at 14% per annum, a conversion price of CAD$0.06, and a threshold price of CAD$0.12 [2]. - The Company obtained an exemption from the Canadian Securities Exchange regarding certain requirements for convertible debenture amendments [3]. Group 2: Related Party Transactions - The amendment constitutes a "related party transaction" as both Mr. Malcolm and Mr. Dhaliwal are directors of the Company, requiring formal valuation and minority shareholder approval unless exemptions apply [4]. - The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements, asserting that the fair market value involved does not exceed 25% of the Company's market capitalization [5]. - The Board of Directors unanimously approved the Amendment, with Mr. Malcolm and Mr. Dhaliwal abstaining from the resolution [6]. Group 3: Company Overview - Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, providing quality medical and recreational products to consumers [8]. - The Company is actively expanding through exports to international markets, positioning itself for sustained growth and new revenue opportunities [8].

Core Viewpoint - Herbal Dispatch Inc. has commenced trading on the OTCQB Venture Market under the ticker symbol "LUFFF", enhancing accessibility for U.S. investors and increasing the company's visibility within the North American investment community [1][2]. Company Overview - Herbal Dispatch Inc. is a leading operator of cannabis e-commerce platforms in Canada, providing quality medical and recreational products to consumers at competitive prices [5]. - The company is actively expanding through exports to international markets, positioning itself for sustained growth and new revenue opportunities [5]. Market Positioning - The OTCQB listing is expected to improve liquidity and visibility for U.S. shareholders, allowing the company to capitalize on growing optimism in the American cannabis sector [3]. - Recent executive actions by the U.S. administration to expedite the rescheduling of cannabis to Schedule III under the Controlled Substances Act have generated positive investor sentiment, indicating greater federal recognition of cannabis's medical applications [3]. Strategic Initiatives - The CEO of Herbal Dispatch emphasized the importance of the OTCQB upgrade as a reflection of the company's commitment to higher standards of transparency and broader access for investors [4]. - The company is executing strategic growth initiatives in the European cannabis market, which strengthens its capital markets strategy [4].

Core Insights - Herbal Dispatch Inc. has successfully completed its first export of 298 kg of medical cannabis to the German market, facilitated through a new partnership with a EU-GMP licensed processor in Portugal, indicating strong revenue potential for 2026 and beyond [1][2][4] Company Summary - Herbal Dispatch operates a leading cannabis e-commerce and distribution platform, focusing on providing high-quality cannabis products to consumers in Canada [5] - The company aims to leverage its EU-GMP compliant processing in Portugal to supply the high-demand German medical cannabis market, which is the largest in the EU [4][3] Industry Summary - Germany's medical cannabis market is experiencing rapid growth, with record imports exceeding 140 tonnes in the first nine months of 2025, driven by increasing patient demand and a higher annual import quota of approximately 192.5 tonnes [2][3] - The strategic partnership with the Portuguese processor positions Herbal Dispatch to capitalize on the expanding market in Germany, offering significant long-term growth opportunities through recurring exports [3][4]

Core Insights - Herbal Dispatch Inc. achieved significant milestones in 2025, including notable sales growth and the introduction of new products, positioning the company well for 2026 [2][5] Financial Performance - Preliminary gross sales for Q4 2025 reached $6.2 million, a 214% increase from $2.9 million in Q4 2024 [7] - Preliminary gross sales for fiscal 2025 totaled $16.5 million, reflecting a 38% increase from $12.0 million in 2024 [7] - The company expects Q4 2025 gross margins to be similar to those reported in recent quarters [4] Strategic Initiatives - The company completed an oversubscribed $2 million private placement in October 2025 to fund growth initiatives [7] - Key strategic priorities for 2026 include enhancing medical cannabis sales to veterans, expanding recreational sales, and growing B2B exports [6][8] Market Expansion - The company aims for 30% year-over-year growth in veteran customer acquisition and to maintain a retention rate above 89% [8] - Herbal Dispatch targets 40% year-over-year growth in recreational sales, with plans to expand SKU counts in British Columbia from 44 to over 100 [8] - The company plans to triple export volumes by 2028, focusing on existing markets and entering new ones [8]

Core Viewpoint - Herbal Dispatch Inc. has granted 2,760,000 restricted share units (RSUs) to its officers, directors, employees, and consultants as part of its stock option plan to retain key personnel and ensure competitive compensation [1][4]. Group 1: RSU Details - The RSUs will vest in three equal installments on July 1, 2026, January 1, 2027, and July 1, 2027, contingent upon the individuals remaining "Eligible Persons" as defined in the plan [2]. - Each RSU represents the right to receive one common share in the capital of the Company upon vesting, subject to the terms of the plan [3]. Group 2: Company Overview - Herbal Dispatch operates leading cannabis e-commerce platforms, focusing on providing high-quality cannabis products at affordable prices [5]. - The flagship marketplace, herbaldispatch.com, offers exclusive access to small-batch craft cannabis flower and a variety of other product formats [5].

Core Insights - The reclassification of cannabis from Schedule I to Schedule III under the U.S. Controlled Substances Act is a transformative breakthrough for the cannabis industry, enhancing its medicinal recognition globally and promoting balanced governance [2][3] Industry Impact - This policy shift aligns federal policy with public opinion in the U.S., where nearly 90% of citizens support some form of legalization, and 74% reside in states with active cannabis programs [3] - The change is expected to foster international collaboration in medical research and acknowledges the efforts of policymakers in countries like Canada that have established consumer-focused cannabis systems [3] Company Opportunities - For Herbal Dispatch, the rescheduling opens new avenues for growth, enabling the company to explore strategic partnerships and expand its product reach into emerging U.S. markets [4] - The company anticipates improved access to capital for technological advancements in its supply chain and customer platforms, enhancing operational efficiencies and positioning it to meet rising global demand [4] - The company expresses support for the U.S. government's decision and reaffirms its commitment to building a credible and innovative cannabis platform for global communities [5]

Core Insights - Herbal Dispatch Inc. has announced a comprehensive Strategic Business Plan for 2026 aimed at driving sustainable growth and enhancing shareholder value, building on its strong historical performance and aiming for significant revenue acceleration while improving gross margins and EBITDA [1][2] Strategic Priorities - **Enhancing Medical Cannabis Sales to Veterans**: The company plans to increase sales in this segment by 200% annually through partnerships with veterans' organizations, development of veteran-specific product bundles, and targeted marketing campaigns. Key performance indicators (KPIs) include 30% year-over-year growth in veteran customer acquisition and maintaining a retention rate above 89% [2][3] - **Expanding Recreational Sales**: Herbal Dispatch aims for 40% year-over-year growth in recreational sales by securing listings with additional provincial cannabis wholesalers and expanding SKU counts in British Columbia from 44 to over 100. KPIs include entering new provinces and boosting British Columbia's market share to 15% [2][5] - **Growing B2B Exports**: The company targets tripling export volumes by 2028, focusing on strengthening partnerships in existing markets and entering new markets. KPIs include 100% year-over-year export revenue growth and adding 2-3 new markets annually [5][6] - **Increasing Investor Awareness**: Herbal Dispatch will engage specialized investor relations and marketing firms to enhance liquidity and attract institutional investors, including quarterly webinars and updated investor materials [6][10] Market Position - Herbal Dispatch holds a unique position among Canadian public cannabis companies, with the longest growth runway in the sector. The company is positioned to simultaneously double medical sales and provincial footprint while tripling exports, which are opportunities that competitors have already exhausted [7][8] Execution Strategy - To execute its strategic priorities, Herbal Dispatch has engaged a coordinated team of agencies, allocating approximately CAD $410,000 for these initiatives, funded from existing working capital [12][13]

Core Insights - Herbal Dispatch Inc. reported record sales of approximately $4.1 million in October 2025, a 273% increase from the average monthly sales of $1.1 million in Q3 2025, driven by strong demand in the recreational cannabis segment [2][3] - The company updated its Q4 2025 sales forecast to between $6.4 million and $7.0 million, representing a potential increase of up to 112% compared to Q3 2025's $3.3 million [3] - The growth is attributed to domestic expansion, strengthening international partnerships, and new product launches on its e-commerce platform [3][4] Sales Performance - October 2025 sales reached $4.1 million, marking the highest monthly sales in the company's history [2] - This performance was significantly influenced by a strike that halted wholesale shipments from British Columbia's primary distribution hubs, leading retailers to seek independent wholesalers [2] Future Outlook - The company anticipates gross sales for Q4 2025 to be between $6.4 million and $7.0 million, supported by ongoing expansion and operational efficiencies [3] - Herbal Dispatch is well-capitalized for sustained growth into 2026 and aims to maintain gross margins consistent with recent quarters [3] Company Profile - Herbal Dispatch operates leading cannabis e-commerce platforms and focuses on providing high-quality cannabis products at affordable prices [5] - The flagship marketplace, herbaldispatch.com, offers exclusive access to small-batch craft cannabis and a variety of product formats [5]

Core Insights - Herbal Dispatch Inc. has appointed Jay Wilgar as a Strategic Advisor, bringing 20 years of experience in startup management and business growth to the company [1][4] - Wilgar previously served as CEO and Chairman of Newstrike Brands Ltd., where he raised over $150 million and led a $260 million sale to Hexo Corp, which was later acquired by Tilray Corp [2] - Herbal Dispatch aims to leverage Wilgar's expertise to enhance its cannabis distribution platforms and expand both domestically and internationally [4][5] Company Overview - Herbal Dispatch operates leading cannabis e-commerce platforms in Canada, focusing on providing high-quality cannabis and related products at affordable prices [6] - The company's flagship marketplace offers exclusive access to small-batch craft cannabis and a diverse range of products [6] Strategic Goals - The company is positioned to lead in Canada's medical and recreational cannabis markets, as well as in global export opportunities [5] - Wilgar's experience and relationships are expected to accelerate the company's growth phase [5]

Core Insights - Herbal Dispatch Inc. is experiencing significant growth opportunities due to the ongoing BCGEU strike, which has disrupted central distribution operations at the BC Liquor Distribution Branch, leading retailers to rely on independent wholesalers and direct delivery programs [1][2] Group 1: Market Impact - The LDB typically distributes around $50 million in cannabis to BC dispensaries each month, and the closure of these distribution centers has resulted in a substantial increase in order volumes for Herbal Dispatch as retailers seek to maintain inventory [2] - Prior to the strike, Herbal Dispatch held a 35% share of BC's direct delivery market, and with the LDB's central distribution offline, the company is capitalizing on increased demand, enhancing its market penetration [3] Group 2: Strategic Advantages - Herbal Dispatch's scalable e-commerce platform and strong relationships with local producers enable efficient direct-to-retailer fulfillment, ensuring dispensaries remain well-stocked during the disruption [3] - The company anticipates that the strengthened partnerships with retailers during this period will foster long-term loyalty and drive sustained growth in its direct delivery operations, enhancing market leadership and shareholder value [4] Group 3: Commitment to Retailers - Herbal Dispatch remains dedicated to supporting BC's cannabis retailers and will continue to monitor the situation closely, providing updates as developments unfold [5]